Global Automotive Pedestrian Protection Systems (PPS) Market by Manufacturers, Countries, Type and Application, Forecast to 2023

January 2019 | 149 pages | ID: GE316B617A8EN
GlobalInfoResearch

Abstracts

Automotive pedestrian protection system (PPS) is a system used to avoid a pedestrian's slam with the car. In case of frontal collisions with pedestrians, sensors in front of the vehicle activates the PPS. The complete section of PPS consists of several technologies such as automatic braking and collision avoidance, advanced driver assistance systems, brake assist, driver caution, external airbags, and pop-up bonnets.

Scope of the Report:

This report studies the Automotive Pedestrian Protection Systems (PPS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Automotive Pedestrian Protection Systems (PPS) market by product type and applications/end industries.
The global Automotive Pedestrian Protection Systems (PPS) market is valued at 1100 million USD in 2017 and is expected to reach 3450 million USD by the end of 2023, growing at a CAGR of 21.0% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Automotive Pedestrian Protection Systems (PPS).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Audi AG
• Volvo Car Corporation
• Continental AG
• Robert Bosch GmbH
• Toyota Motor Corporation
• ZF Friedrichshafen AG
• Autoliv Inc
• Mobileye N.V
• Subaru Corporation
• Valeo
• Honda Motor Co., Ltd
• General Motors
• Ford Motor Company
• Daimler AG
• Denso Corporation
• Nissan Motor Corporation
• BMW AG
• Magneti Marelli SpA

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Active Pedestrian Protection System
• Passive Pedestrian Protection System

Market Segment by Applications, can be divided into

• Passenger Cars (ICE Vehicles)
• Commercial Vehicles (ICE Vehicles)
• Electric & Hybrid Vehicles

Contents

1 AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET OVERVIEW

1.1 Product Overview and Scope of Automotive Pedestrian Protection Systems (PPS)
1.2 Classification of Automotive Pedestrian Protection Systems (PPS) by Types
  1.2.1 Global Automotive Pedestrian Protection Systems (PPS) Revenue Comparison by Types (2017-2023)
  1.2.2 Global Automotive Pedestrian Protection Systems (PPS) Revenue Market Share by Types in 2017
  1.2.3 Active Pedestrian Protection System
  1.2.4 Passive Pedestrian Protection System
1.3 Global Automotive Pedestrian Protection Systems (PPS) Market by Application
  1.3.1 Global Automotive Pedestrian Protection Systems (PPS) Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Passenger Cars (ICE Vehicles)
  1.3.3 Commercial Vehicles (ICE Vehicles)
  1.3.4 Electric & Hybrid Vehicles
1.4 Global Automotive Pedestrian Protection Systems (PPS) Market by Regions
  1.4.1 Global Automotive Pedestrian Protection Systems (PPS) Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Automotive Pedestrian Protection Systems (PPS) Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Automotive Pedestrian Protection Systems (PPS) Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Automotive Pedestrian Protection Systems (PPS) Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Automotive Pedestrian Protection Systems (PPS) Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Automotive Pedestrian Protection Systems (PPS) Status and Prospect (2013-2023)
1.5 Global Market Size of Automotive Pedestrian Protection Systems (PPS) (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Audi AG
  2.1.1 Business Overview
  2.1.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Audi AG Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Volvo Car Corporation
  2.2.1 Business Overview
  2.2.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Volvo Car Corporation Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Continental AG
  2.3.1 Business Overview
  2.3.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Continental AG Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Robert Bosch GmbH
  2.4.1 Business Overview
  2.4.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Robert Bosch GmbH Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Toyota Motor Corporation
  2.5.1 Business Overview
  2.5.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Toyota Motor Corporation Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.6 ZF Friedrichshafen AG
  2.6.1 Business Overview
  2.6.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 ZF Friedrichshafen AG Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Autoliv Inc
  2.7.1 Business Overview
  2.7.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Autoliv Inc Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mobileye N.V
  2.8.1 Business Overview
  2.8.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Mobileye N.V Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Subaru Corporation
  2.9.1 Business Overview
  2.9.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Subaru Corporation Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Valeo
  2.10.1 Business Overview
  2.10.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Valeo Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Honda Motor Co., Ltd
  2.11.1 Business Overview
  2.11.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Honda Motor Co., Ltd Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.12 General Motors
  2.12.1 Business Overview
  2.12.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 General Motors Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.13 Ford Motor Company
  2.13.1 Business Overview
  2.13.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Ford Motor Company Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.14 Daimler AG
  2.14.1 Business Overview
  2.14.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Daimler AG Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.15 Denso Corporation
  2.15.1 Business Overview
  2.15.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Denso Corporation Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.16 Nissan Motor Corporation
  2.16.1 Business Overview
  2.16.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Nissan Motor Corporation Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.17 BMW AG
  2.17.1 Business Overview
  2.17.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 BMW AG Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)
2.18 Magneti Marelli SpA
  2.18.1 Business Overview
  2.18.2 Automotive Pedestrian Protection Systems (PPS) Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Magneti Marelli SpA Automotive Pedestrian Protection Systems (PPS) Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET COMPETITION, BY PLAYERS

3.1 Global Automotive Pedestrian Protection Systems (PPS) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Automotive Pedestrian Protection Systems (PPS) Players Market Share
  3.2.2 Top 10 Automotive Pedestrian Protection Systems (PPS) Players Market Share
3.3 Market Competition Trend

4 GLOBAL AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET SIZE BY REGIONS

4.1 Global Automotive Pedestrian Protection Systems (PPS) Revenue and Market Share by Regions
4.2 North America Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
4.3 Europe Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
4.5 South America Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) REVENUE BY COUNTRIES

5.1 North America Automotive Pedestrian Protection Systems (PPS) Revenue by Countries (2013-2018)
5.2 USA Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
5.3 Canada Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
5.4 Mexico Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

6 EUROPE AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) REVENUE BY COUNTRIES

6.1 Europe Automotive Pedestrian Protection Systems (PPS) Revenue by Countries (2013-2018)
6.2 Germany Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
6.3 UK Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
6.4 France Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
6.5 Russia Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
6.6 Italy Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) REVENUE BY COUNTRIES

7.1 Asia-Pacific Automotive Pedestrian Protection Systems (PPS) Revenue by Countries (2013-2018)
7.2 China Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
7.3 Japan Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
7.4 Korea Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
7.5 India Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) REVENUE BY COUNTRIES

8.1 South America Automotive Pedestrian Protection Systems (PPS) Revenue by Countries (2013-2018)
8.2 Brazil Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
8.3 Argentina Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
8.4 Colombia Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) BY COUNTRIES

9.1 Middle East and Africa Automotive Pedestrian Protection Systems (PPS) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
9.3 UAE Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
9.4 Egypt Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)
9.6 South Africa Automotive Pedestrian Protection Systems (PPS) Revenue and Growth Rate (2013-2018)

10 GLOBAL AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET SEGMENT BY TYPE

10.1 Global Automotive Pedestrian Protection Systems (PPS) Revenue and Market Share by Type (2013-2018)
10.2 Global Automotive Pedestrian Protection Systems (PPS) Market Forecast by Type (2018-2023)
10.3 Active Pedestrian Protection System Revenue Growth Rate (2013-2023)
10.4 Passive Pedestrian Protection System Revenue Growth Rate (2013-2023)

11 GLOBAL AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET SEGMENT BY APPLICATION

11.1 Global Automotive Pedestrian Protection Systems (PPS) Revenue Market Share by Application (2013-2018)
11.2 Automotive Pedestrian Protection Systems (PPS) Market Forecast by Application (2018-2023)
11.3 Passenger Cars (ICE Vehicles) Revenue Growth (2013-2018)
11.4 Commercial Vehicles (ICE Vehicles) Revenue Growth (2013-2018)
11.5 Electric & Hybrid Vehicles Revenue Growth (2013-2018)

12 GLOBAL AUTOMOTIVE PEDESTRIAN PROTECTION SYSTEMS (PPS) MARKET SIZE FORECAST (2018-2023)

12.1 Global Automotive Pedestrian Protection Systems (PPS) Market Size Forecast (2018-2023)
12.2 Global Automotive Pedestrian Protection Systems (PPS) Market Forecast by Regions (2018-2023)
12.3 North America Automotive Pedestrian Protection Systems (PPS) Revenue Market Forecast (2018-2023)
12.4 Europe Automotive Pedestrian Protection Systems (PPS) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Automotive Pedestrian Protection Systems (PPS) Revenue Market Forecast (2018-2023)
12.6 South America Automotive Pedestrian Protection Systems (PPS) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Automotive Pedestrian Protection Systems (PPS) Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Anti-epileptic Drugs for Pediatrics Picture
Table Product Specifications of Anti-epileptic Drugs for Pediatrics
Figure Global Anti-epileptic Drugs for Pediatrics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-epileptic Drugs for Pediatrics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-epileptic Drugs for Pediatrics by Types in 2017
Figure 1st generation Picture
Table Major Manufacturers of 1st generation
Figure 2nd generation Picture
Table Major Manufacturers of 2nd generation
Figure 3rd generation Picture
Table Major Manufacturers of 3rd generation
Figure Anti-epileptic Drugs for Pediatrics Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Retail pharmacies Picture
Figure Online pharmacies Picture
Figure United States Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2013-2023)
Table Mylan N.V Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan N.V Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Mylan N.V Anti-epileptic Drugs for Pediatrics Product
Table Mylan N.V Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan N.V Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Mylan N.V Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Cephalon, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Cephalon, Inc Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product
Table Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Cephalon, Inc Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table GlaxoSmithKline plc Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Janssen Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Novartis AG Anti-epileptic Drugs for Pediatrics Product
Table Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Novartis AG Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Pfizer, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer, Inc Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product
Table Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Pfizer, Inc Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Sanofi S.A Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi S.A Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Sanofi S.A Anti-epileptic Drugs for Pediatrics Product
Table Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Sanofi S.A Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table UCB Pharma Limited Headquarter, Established, Main Business and Finance Overview (2017)
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Sunovion Pharmaceuticals Limited Headquarter, Established, Main Business and Finance Overview (2017)
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Valeant Pharmaceuticals International, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Production Bases, Sales Regions and Major Competitors
Table Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product
Table Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales Market Share in 2017
Figure Global Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Revenue Market Share in 2017
Table Zogenix
Table Zogenix Anti-epileptic Drugs for Pediatrics
Table GW Pharmaceuticals
Table GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics
Table Insys
Table Insys Anti-epileptic Drugs for Pediatrics
Table Zynerba
Table Zynerba Anti-epileptic Drugs for Pediatrics
Table Global Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table Global Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table Global Anti-epileptic Drugs for Pediatrics Price by Manufacturer (2016-2017)
Figure Top 3 Anti-epileptic Drugs for Pediatrics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-epileptic Drugs for Pediatrics Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Global Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales by Regions (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Regions (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Revenue by Regions (2013-2018)
Figure Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Regions in 2013
Figure Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Regions in 2017
Figure North America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure North America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Figure South America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure South America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Figure North America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales by Countries (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2013-2018)
Figure North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2013
Figure North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2017
Table North America Anti-epileptic Drugs for Pediatrics Revenue by Countries (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2013-2018)
Figure North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2013
Figure North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2017
Figure United States Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Canada Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Mexico Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table North America Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table North America Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Revenue by Application (2013-2018)
Table North America Anti-epileptic Drugs for Pediatrics Revenue Share by Application (2013-2018)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales by Countries (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue by Countries (2013-2018)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2016
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2017
Figure Germany Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure UK Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure France Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Russia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Italy Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table Europe Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table Europe Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue by Application (2013-2018)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue Share by Application (2013-2018)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales by Countries (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries 2017
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue by Countries (2013-2018)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries 2017
Figure China Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Japan Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Korea Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure India Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue by Application (2013-2018)
Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Share by Application (2013-2018)
Figure South America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales by Countries (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2013-2018)
Figure South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2017
Table South America Anti-epileptic Drugs for Pediatrics Revenue by Countries (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2013-2018)
Figure South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2017
Figure Brazil Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Argentina Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Colombia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table South America Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table South America Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Revenue by Application (2013-2018)
Table South America Anti-epileptic Drugs for Pediatrics Revenue Share by Application (2013-2018)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales by Countries (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2017
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue by Countries (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure UAE Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Egypt Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure Nigeria Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Figure South Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue by Application (2013-2018)
Table Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Share by Application (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales by Type (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales Share by Type (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Revenue by Type (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2013-2018)
Figure Global 1st generation Sales Growth (2013-2018)
Figure Global 1st generation Price (2013-2018)
Figure Global 2nd generation Sales Growth (2013-2018)
Figure Global 2nd generation Price (2013-2018)
Figure Global 3rd generation Sales Growth (2013-2018)
Figure Global 3rd generation Price (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales by Application (2013-2018)
Table Global Anti-epileptic Drugs for Pediatrics Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Retail pharmacies Sales Growth (2013-2018)
Figure Global Online pharmacies Sales Growth (2013-2018)
Figure Global Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Regions (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2018-2023)
Figure Europe Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2018-2023)
Figure South America Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Type (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Type (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Application (2018-2023)
Table Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List